0.0070
0.0000
(0.00%)
At close: April 10 at 11:04:05 AM GMT+10
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. David Ali | CEO, MD & Executive Director | 280.82k | -- | -- |
| Mr. Pablo Neyertz | Director of Finance | 172.94k | -- | -- |
| Associate Prof. Hassan Bakos | Director of Operations | 242.89k | -- | -- |
| Prof. R. John Aitken Ph.D., ScD FRSE | Scientific Director | 275.7k | -- | -- |
| Mr. Andrew William Metcalfe B.Bus., C.P.A., CPA, DipAppCorpGov, FCIS, FGIA, MA | Company Secretary | -- | -- | 1965 |
Memphasys Limited
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company primarily develops Felix, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid oxidative stress assay; and AI-Port. In addition, the company offers ambient temperature storage product for human sperm. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
Corporate Governance
Memphasys Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 28, 2025 at 10:59 AM UTC
Memphasys Limited Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
NYR.AX Nyrada Inc.
0.1200
+9.09%
BTC.AX BTC Health Limited
0.0500
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
TRP.AX Tissue Repair Ltd
0.2350
-4.08%
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%
CMB.AX Cambium Bio Limited
0.2800
0.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
PYC.AX PYC Therapeutics Limited
0.9800
-3.45%